| Literature DB >> 29345579 |
Fatima Ardito1, Giovanni Di Gioia1, Mario Roberto Pellegrino1, Lorenzo Lo Muzio1.
Abstract
The use of nutraceuticals as protection drugs against chronic diseases gained a vast success. Many studies found that nutraceuticals may reduce the tumorigenic actions of carcinogens, inhibiting the adhesion and proliferation of tumor cells. Genistein is a natural isoflavone preventing osteoporosis, menopause problems and heart diseases. It is also known in China and Japan for its anticancer properties. The available treatment protocols for Head and neck squamous cell cancer (HNSCC) have led to poor results and new therapies are necessary. In this paper, we will review anticancer therapeutic potential of genistein and in vitro and in vivo studies that suggest its potential role in the treatments of HNSCC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Genistein; HNSCC; Isoflavone; Nutraceuticals; OSCC; Therapy.
Mesh:
Substances:
Year: 2018 PMID: 29345579 DOI: 10.2174/1568026618666180116122650
Source DB: PubMed Journal: Curr Top Med Chem ISSN: 1568-0266 Impact factor: 3.295